NO940777D0 - Anvendelse av et pregnanderivat - Google Patents

Anvendelse av et pregnanderivat

Info

Publication number
NO940777D0
NO940777D0 NO940777A NO940777A NO940777D0 NO 940777 D0 NO940777 D0 NO 940777D0 NO 940777 A NO940777 A NO 940777A NO 940777 A NO940777 A NO 940777A NO 940777 D0 NO940777 D0 NO 940777D0
Authority
NO
Norway
Prior art keywords
derivative
pregnancy
alpha
pregnane
oacyl
Prior art date
Application number
NO940777A
Other languages
English (en)
Other versions
NO307447B1 (no
NO940777L (no
Inventor
Godefridus Hermanus Jo Deckers
Helenius Jan Kloosterboer
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO940777D0 publication Critical patent/NO940777D0/no
Publication of NO940777L publication Critical patent/NO940777L/no
Publication of NO307447B1 publication Critical patent/NO307447B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fats And Perfumes (AREA)
NO940777A 1993-03-05 1994-03-04 Anvendelse av et pregnanderivat NO307447B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93200631 1993-03-05

Publications (3)

Publication Number Publication Date
NO940777D0 true NO940777D0 (no) 1994-03-04
NO940777L NO940777L (no) 1994-09-06
NO307447B1 NO307447B1 (no) 2000-04-10

Family

ID=8213673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940777A NO307447B1 (no) 1993-03-05 1994-03-04 Anvendelse av et pregnanderivat

Country Status (14)

Country Link
US (1) US5512556A (no)
EP (1) EP0613687B1 (no)
JP (1) JP3391539B2 (no)
KR (1) KR100312061B1 (no)
AT (1) ATE180669T1 (no)
AU (1) AU671706B2 (no)
CA (1) CA2116829C (no)
DE (1) DE69418744T2 (no)
DK (1) DK0613687T3 (no)
ES (1) ES2134313T3 (no)
GR (1) GR3031114T3 (no)
NO (1) NO307447B1 (no)
NZ (1) NZ260017A (no)
ZA (1) ZA941464B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69530308T2 (de) * 1994-09-22 2003-10-16 Akzo Nobel Nv Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
EP1275379A3 (en) * 1998-10-16 2003-03-26 Akzo Nobel N.V. Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
AU5209600A (en) * 1999-04-06 2000-10-23 Akzo Nobel N.V. Orally active androgens
PL353826A1 (en) * 1999-09-06 2003-12-01 Akzo Nobel N.V.Akzo Nobel N.V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
JP2004505093A (ja) 2000-07-28 2004-02-19 アクゾ・ノベル・エヌ・ベー １６α−メチルまたはエチル置換エストロゲン
DE60220699T2 (de) * 2001-10-18 2008-03-06 Norton Healthcare Ltd. Tibolonformulierungen
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
RU2004125594A (ru) * 2002-01-22 2005-03-10 Акцо Нобель Н.В. (NL) Применение тиболона при лечение симптомов, связанных с введением лекарств, препятствующих синтезу эндогенного эстрогена
US20060051420A1 (en) * 2002-11-20 2006-03-09 Pieter De Haan Pharmaceutical tablets containing tibolone and a coating
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
US20060211667A1 (en) * 2005-03-21 2006-09-21 Eric Marchewitz Use of pregnane steroid derivatives for enhancing physical performance
CN116987680A (zh) * 2022-04-25 2023-11-03 复旦大学 支链氨基酸转氨酶1的功能获得性突变体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
FR2706454B1 (fr) * 1993-06-17 1995-09-15 Roussel Uclaf Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
DK0613687T3 (da) 1999-12-06
NO307447B1 (no) 2000-04-10
DE69418744T2 (de) 1999-11-11
CA2116829A1 (en) 1994-09-06
GR3031114T3 (en) 1999-12-31
EP0613687B1 (en) 1999-06-02
KR940021064A (ko) 1994-10-17
AU5754294A (en) 1994-09-08
ZA941464B (en) 1994-09-27
US5512556A (en) 1996-04-30
AU671706B2 (en) 1996-09-05
NO940777L (no) 1994-09-06
JP3391539B2 (ja) 2003-03-31
CA2116829C (en) 2004-09-14
ATE180669T1 (de) 1999-06-15
DE69418744D1 (de) 1999-07-08
ES2134313T3 (es) 1999-10-01
EP0613687A1 (en) 1994-09-07
KR100312061B1 (ko) 2001-12-28
NZ260017A (en) 1997-06-24
JPH072673A (ja) 1995-01-06

Similar Documents

Publication Publication Date Title
RU2088589C1 (en) Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
AU7815791A (en) Heterocyclene derivatives
HU9600834D0 (en) Quinazoline derivatives
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
NO307447B1 (no) Anvendelse av et pregnanderivat
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
TW223016B (no)
MY114282A (en) Anthracycline derivatives
GB9302046D0 (en) Antiumoral compound-v
HU9400908D0 (en) Pharmaceutical compositions for treatng skin disorders
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
AP9400608A0 (en) "New nicotinic acid derivative".
DE69528984T2 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
TH15815A (th) การใช้อนุพันธ์เพรคเนม
DE3882956D1 (de) Gegen die zerebrale insuffizienz wirksame verbindungen.
KR910000786A (ko) 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도
HK1007857A1 (en) New compound leustroducsin H its preparation and its therapeutic use
TH10441B (th) การใช้อนุพันธ์เพรคเนม